We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 66

Unprecedented challenges facing the automotive sector demand urgent re-evaluation of existing IP strategies
  • Gowling WLG
  • USA
  • July 10 2018

The car industry faces, simultaneously, the emergence of connected and autonomous vehicles and regulatory pressures to eliminate the internal


Strategies for the Shadows: Protecting your Company’s IP Rights on the Dark Web
  • Gowling WLG
  • USA, Canada
  • July 9 2018

Companies already face formidable challenges in protecting their IP rights online, but a new threat is emerging from the shadows - the growing


A guide to how patent law works
  • Gowling WLG
  • USA, European Union
  • June 14 2018

Patent and intellectual property laws are essential to enabling organisations to be able to gain protection for the innovations that they develop. The


NAFTA renegotiations the USA’s objectives
  • Gowling WLG
  • USA, Canada
  • July 19 2017

United States Trade Representative Robert Lighthizer has released a Summary of the USA's North American Free Trade Agreement


Save the earth...and be sued?
  • Gowling WLG
  • USA
  • June 9 2010

The automobile manufacturer American Honda Motor Co. has been sued for trade-mark infringement in California by the environmental group Save the Earth, which objects to the presence of an actor wearing a T-shirt bearing its logo in a Honda Civic commercial


U.S. Senate votes against bill allowing Americans to import prescription drugs
  • Gowling WLG
  • USA
  • January 20 2010

In December, the Senate rejected an amendment by Senator Dorgan to allow American pharmacies and drug wholesalers to import federally approved drugs from abroad


U.S. drug prices challenged
  • Gowling WLG
  • USA
  • January 20 2010

In December, brand pharmaceutical companies defended themselves before the House Energy and Commerce health panel against complaints over reports, including one by the AARP (which represents 40 million older Americans), that drug prices continued to outstrip inflation in 2009


Obama moving to renegotiate biologics exclusivity period
  • Gowling WLG
  • USA
  • January 20 2010

In the United States, biologics are not regulated under the Hatch-Waxman Act, which governs approval of conventional generic "small molecule" pharmaceuticals


At a level crossing: open-source software licensing compliance in a post Jacobsen v. Katzer world
  • Gowling WLG
  • USA
  • August 15 2009

By clarifying the enforceability of open-source software licences, the recent decision in Jacobsen v. Katzer has left the software licensing world at an important crossroad


Google suffers setback in Adword dispute in US Court of Appeals
  • Gowling WLG
  • USA
  • April 16 2009

The US Court of Appeals for the Second Circuit has allowed an appeal by Rescuecom that Google's use of Rescuecom's trade mark could amount to "use in commerce"